Author/Creator: Nachar, Victoria R. - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Nachar, Victoria R.

1. Chemotherapy Remote Care Monitoring Program: Integration of SMS Text Patient-Reported Outcomes in the Electronic Health Record and Pharmacist Intervention for Chemotherapy-Induced Nausea and Vomiting. Issue 9 (September 2021)

Authors:: Hough, Shannon; McDevitt, Rachel; Nachar, Victoria R.; Kraft, Shawna; Brown, Anna; Christen, Catherine; Frame, David; Smerage, Jeffrey B.
Journal:: JCO oncology practice
Issue:: Volume 17:Issue 9(2021)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. Contemporary treatment options for a classical disease: Advanced Hodgkin lymphoma. (April 2020)

Authors:: Reid, Justin H.; Marini, Bernard L.; Nachar, Victoria R.; Brown, Anna M.; Devata, Sumana; Perissinotti, Anthony J.
Journal:: Critical reviews in oncology/hematology
Issue:: Volume 148(2020)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. Impact of a vincristine dose cap on the incidence of neuropathies with DA-EPOCH-R for the treatment of aggressive lymphomas. Issue 5 (15th April 2020)

Authors:: Weis, Taylor M.; Marini, Bernard L.; Nachar, Victoria R.; Brown, Anna M.; Phillips, Tycel J.; Brown, Julia; Wilcox, Ryan A.; Kaminski, Mark S.; Devata, Sumana; Perissinotti, Anthony J.
Journal:: Leukemia & lymphoma
Issue:: Volume 61:Issue 5(2020)
Page Start:: 1126
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

4. Impact of Extended-Interval Versus Standard Dosing of Zoledronic Acid on Skeletal Events in Non–Small-Cell Lung Cancer and Small-Cell Lung Cancer Patients With Bone Metastases. Issue 6 (June 2021)

Authors:: Tam, Andrew H.; Schepers, Allison J.; Qin, Angel; Nachar, Victoria R.
Journal:: Annals of pharmacotherapy
Issue:: Volume 55:Issue 6(2021)
Page Start:: 697
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

5. Incidence and risk factors for bacterial infection using bortezomib, lenalidomide, and dexamethasone (RVd) in newly diagnosed multiple myeloma. Issue 2 (28th January 2023)

Authors:: Bici, Anisa; Pianko, Matthew J.; Nachar, Victoria R.
Journal:: Leukemia & lymphoma
Issue:: Volume 64:Issue 2(2023)
Page Start:: 407
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

6. Incorporation of novel therapies for the management of sickle cell disease: A pharmacist's perspective. (April 2022)

Authors:: Dela-Pena, Jacqueline C.; King, Madeleine A.; Brown, Julia; Nachar, Victoria R.
Journal:: Journal of oncology pharmacy practice
Issue:: Volume 28:Number 3(2022)
Page Start:: 646
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

7. Late-onset complications with bendamustine versus CHOP or CVP based chemoimmunotherapy in indolent Non-Hodgkin's lymphoma. Issue 13 (10th November 2021)

Authors:: Baek, Grace T.; Mathis, Noah J.; Perissinotti, Anthony J.; Marini, Bernard L.; Brown, Anna; Phillips, Tycel J.; Wilcox, Ryan A.; Nachar, Victoria R.
Journal:: Leukemia & lymphoma
Issue:: Volume 62:Issue 13(2021)
Page Start:: 3138
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

8. Optimal sequence of daratumumab and elotuzumab in relapsed and refractory multiple myeloma. Issue 3 (23rd February 2020)

Authors:: Hoylman, Emily; Brown, Anna; Perissinotti, Anthony J.; Marini, Bernard L.; Pianko, Matthew; Ye, Jing Christine; Campagnaro, Erica; Nachar, Victoria R.
Journal:: Leukemia & lymphoma
Issue:: Volume 61:Issue 3(2020)
Page Start:: 691
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

9. Predictors for requiring re-induction chemotherapy in acute myeloid leukemia patients with residual disease on day 14 bone marrow assessment. (December 2017)

Authors:: Nachar, Victoria R.; Perissinotti, Anthony J.; Scappaticci, Gianni B.; Bixby, Dale L.; Marini, Bernard L.
Journal:: Leukemia research
Issue:: Volume 63(2017:Dec.)
Page Start:: 56
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

10. The FOSSIL Study: FLAG or standard 7+3 induction therapy in secondary acute myeloid leukemia. (July 2018)

Authors:: Vulaj, Vera; Perissinotti, Anthony J.; Uebel, James R.; Nachar, Victoria R.; Scappaticci, Gianni B.; Crouch, Ashley; Bixby, Dale L.; Burke, Patrick W.; Maillard, Ivan; Talpaz, Moshe; Marini, Bernard L.
Journal:: Leukemia research
Issue:: Volume 70(2018)
Page Start:: 91
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗